350 related articles for article (PubMed ID: 23410496)
1. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
[TBL] [Abstract][Full Text] [Related]
3. Biased G Protein-Independent Signaling of Dopamine D
Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz JC; Sokoloff P
Eur J Neurosci; 1998 May; 10(5):1676-86. PubMed ID: 9751140
[TBL] [Abstract][Full Text] [Related]
5. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.
Collo G; Bono F; Cavalleri L; Plebani L; Mitola S; Merlo Pich E; Millan MJ; Zoli M; Maskos U; Spano P; Missale C
Mol Pharmacol; 2013 Jun; 83(6):1176-89. PubMed ID: 23543412
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
9. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2011 Jun; 660(2-3):341-50. PubMed ID: 21515255
[TBL] [Abstract][Full Text] [Related]
11. Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice.
Dunleavy M; Provenzano G; Henshall DC; Bozzi Y
J Mol Neurosci; 2013 Jan; 49(1):202-10. PubMed ID: 23188702
[TBL] [Abstract][Full Text] [Related]
12. Selective D
Manvich DF; Petko AK; Branco RC; Foster SL; Porter-Stransky KA; Stout KA; Newman AH; Miller GW; Paladini CA; Weinshenker D
Neuropsychopharmacology; 2019 Jul; 44(8):1445-1455. PubMed ID: 30879021
[TBL] [Abstract][Full Text] [Related]
13. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
[TBL] [Abstract][Full Text] [Related]
15. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
Le Foll B; Diaz J; Sokoloff P
Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
[TBL] [Abstract][Full Text] [Related]
16. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
[TBL] [Abstract][Full Text] [Related]
17. The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor.
Bongers G; Sallmen T; Passani MB; Mariottini C; Wendelin D; Lozada A; Marle Av; Navis M; Blandina P; Bakker RA; Panula P; Leurs R
J Neurochem; 2007 Oct; 103(1):248-58. PubMed ID: 17623045
[TBL] [Abstract][Full Text] [Related]
18. The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.
Rapanelli M; Frick LR; Horn KD; Schwarcz RC; Pogorelov V; Nairn AC; Pittenger C
J Biol Chem; 2016 Sep; 291(40):21042-21052. PubMed ID: 27510032
[TBL] [Abstract][Full Text] [Related]
19. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
20. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
